Tubulocystic Renal Cell Carcinoma of the Native Kidney in a Renal Transplant Recipient: A Rare Case Report.

Autor: Ruch B; Hume-Lee Transplant Center, Virginia Commonwealth University, Richmond, VA, USA., Limkemann AJ; Hume-Lee Transplant Center, Virginia Commonwealth University, Richmond, VA, USA., Garcia P; Department of Pathology, Virginia Commonwealth University, Richmond, VA, USA., Benedict C; School of Medicine, Virginia Commonwealth University, Richmond, VA 23298, USA., Gupta G; Hume-Lee Transplant Center, Virginia Commonwealth University, Richmond, VA, USA., Levy M; Hume-Lee Transplant Center, Virginia Commonwealth University, Richmond, VA, USA., Sharma A; Hume-Lee Transplant Center, Virginia Commonwealth University, Richmond, VA, USA.
Jazyk: angličtina
Zdroj: Case reports in nephrology [Case Rep Nephrol] 2020 Oct 14; Vol. 2020, pp. 7145652. Date of Electronic Publication: 2020 Oct 14 (Print Publication: 2020).
DOI: 10.1155/2020/7145652
Abstrakt: Tubulocystic renal cell carcinoma (TCC) is a rare and newly recognized variant of renal cell carcinoma, which may mimic benign cystic disease of the kidney. To our knowledge, we present the first reported case of a patient who, despite standard preoperative workup, developed TCC of his native kidney soon after receiving kidney transplantation. He was appropriately treated with native nephrectomy and has had no signs of reoccurrence 7 years postoperatively. Given the significant risk of malignancy in renal transplant patients, this case emphasizes the need for close monitoring of native cystic disease before and after transplantation, with low threshold to proceed with surgical intervention.
Competing Interests: The authors declare that they have no conflicts of interest.
(Copyright © 2020 Brianna Ruch et al.)
Databáze: MEDLINE
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje